Hepatology Review

CME : 20

Organized by :   American Seminar Institute (ASI)

Specialties :   Hepatology

FeesPodcasts ( Starting From USD 485 )

Conference Summary

Hepatology Review is organized by American Seminar Institute (ASI).

Course(s) are Appropriate for:
Family Practitioners, Pediatricians, Internists, General Practitioners, Nurses, Nurse Practitioners, Physician Assistants (PA-C's)

Full Course: 20 AMA PRA Category 1 Credits™
Short Course: 10 AMA PRA Category 1 Credits™

Series 4 (HP4) Topics Include: Treatment for Portal Hypertension, HCV Positive Donors and Recipients, Elevated Liver Enzymes, Signs and Symptoms of Sarcoidosis, Hepatitis C-Related Cirrhosis, and more.

Course Topics:
Update on Liver Disease:

Select appropriate treatments for portal hypertension based on severity, cardiac output, and comorbidities; Compare and contrast methods for the management of variceal bleeding in patients with cirrhosis; Assess possible causes and options for the management of sarcopenia in patients with cirrhosis; Identify patients with acute-on-chronic liver failure using clinician assessment or scoring systems; Apply scoring systems to determine eligibility for liver transplantation and probability of survival in patients with acute-on-chronic liver failure.

Cirrhosis/liver Injury:
Characterize hospital readmission in patients with cirrhosis; Assess the effectiveness of interventions for reducing hospital readmissions of patients with cirrhosis; Identify drugs that commonly cause injury to the liver; Differentiate between immune-mediated and metabolic causes of drug-induced liver injury; List clinical and histologic characteristics of various types of drug-induced liver injury.

Hepatitis Update:
Classify the stage of disease in a patient with chronic hepatitis B; Manage hepatitis B in a pregnant woman; Choose among common regimens employing directacting antivirals agents for treatment of hepatitis C; List risk factors for autoimmune hepatitis; Identify patients with autoimmune hepatitis who need pharmacologic treatment or liver transplantation.

Liver Transplantation 2018:
Review the principles of allocation used in organ, and particularly liver, transplantation; Explain the concept of liver transplant redistribution (or broader sharing) to improve fairness in geographic access to transplantation; Discuss the concerns involved with HCV-positive donors and HCV-positive recipients in liver transplantation; Describe the advantages and disadvantages of telehealth in transplant hepatology; Identify conditions and situations that lend themselves well to management via telehealth in hepatology

Liver Chemistries/liver Preservation:
Perform an appropriate workup for a patient with elevated alkaline phosphatase.; Counsel patients on lifestyle modification to manage nonalcoholic fatty liver disease; Identify the possible causes of elevated liver enzymes; Describe how machine perfusion improves preservation of donor livers; Explain the concept of warm perfusion for preservation of donor livers.

Updates on Liver Disease:
Use common liver function tests to diagnose disorders of the liver; Evaluate a patient with suspected ischemic liver injury; List the expected changes in liver function during pregnancy and assess more concerning symptoms; Manage a patient with intrahepatic cholestasis of pregnancy; Diagnose common porphyrias.

Liver Diseases in 2018:
Recognize signs and symptoms of sarcoidosis; Treat skin manifestations of sarcoidosis; Counsel patients about BP targets and management, based on updated hypertension guidelines; Implement colorectal cancer screening, based on American College of Gastroenterology guidelines; Compare the recombinant adjuvanted zoster vaccine with the live zoster vaccine.

Primary Biliary Cholangitis/fatty Liver:
Recognize manifestations of primary biliary cholangitis; Identify risk factors for primary biliary cholangitis; Explain the pathophysiology of nonalcoholic fatty liver disease; Choose appropriate diagnostic tests for the diagnosis of nonalcoholic fatty liver disease; Recommend lifestyle interventions for the management of nonalcoholic fatty liver disease.

Nash/cirrhosis and Hcv:
Counsel patients about the importance of lifestyle intervention in the treatment of nonalcoholic steatohepatitis; Identify the potential therapeutic targets for hepatic fibrosis; Characterize drugs currently in development for the treatment of nonalcoholic steatohepatitis; Adopt general principles for the management of hepatitis C-related cirrhosis; Select appropriate candidates for referral to a liver transplantation center.

Abnormal Liver Function Tests /diabetic Foot Ulcers:
Interpret liver function tests and liver enzyme levels; Identify patients with hepatitis, cholestasis, or cholestatic hepatitis based on physical and laboratory findings; Determine whether further workup is indicated in patients with abnormal liver function results; Stratify risk for foot ulcer in diabetic patients; Educate diabetic patients about proper foot care

Credit Info

  • CME : 20
Contact Us

Toll free Number

1(800) 826-2059



Chat Assistant

Live Chat